Sign in

CIK 0001790340

  • Emerging growth company

Immuneering Corp

Sign in to watch
Ticker
IMRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-500-8080
Business address
245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, MA, 02142
Open-market buys, last 90 days
$89,500
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$89,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Gengos Andrew +$90K Chief Financial Officer 1 filing
Date Insider Transaction Shares Price Value Owned after
2021-08-03 Barrett Scott Chief Medical Officer Conversion · Series B Preferred Stock −2,723 0
2021-08-03 Amin Biren CFO, Treasurer Conversion +2,723 2,723
2021-08-03 Amin Biren CFO, Treasurer Purchase +4,175 $15.00 $63K 6,898
2021-08-03 Amin Biren CFO, Treasurer Conversion · Series B Preferred Stock −2,723 0
2021-07-29 Bookman Michael General Counsel and Secretary Grant or award · Stock Option −101,116 101,116
2021-07-29 BERMAN ANN E Director Grant or award · Stock Option −28,371 28,371

Page 12 of 12 · 226 trades